Navigation Links
America's Pharmaceutical Research Companies Donate $35 Million to Relief Efforts in Haiti; More Help Coming
Date:2/3/2010

WASHINGTON, Feb. 3 /PRNewswire-USNewswire/ -- As the need for health care assistance mounts after the recent catastrophic earthquake in Haiti, America's pharmaceutical research and biotechnology companies continue to provide help.  So far, more than $35 million in medicines, medical supplies and cash have been committed to relief efforts – and that amount is still growing.  The total does not include the contributions of PhRMA member company employees and the many companies committed to matching the pledges of their workers.

PhRMA companies making donations include: Abbott, Amgen Inc., Astellas Pharma US, Inc., AstraZeneca Pharmaceuticals LP, Bayer HealthCare Pharmaceuticals, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Daiichi Sankyo, Inc., Eisai Inc., Endo Pharmaceuticals, Inc., GlaxoSmithKline, Inspire Pharmaceuticals, Inc., Johnson & Johnson, Eli Lilly and Company, Lundbeck Inc., Merck & Co., Inc., Novartis Pharmaceuticals Corporation, Novo Nordisk Inc., Otsuka America, Inc., Pfizer Inc., Purdue Pharma L.P., sanofi-aventis U.S., Takeda Pharmaceuticals North America, Inc. and Talecris.

PhRMA President and CEO Billy Tauzin said: "The day the news broke about the tragedy in Haiti, America's biopharmaceutical companies got to work – coordinating efforts with relief organizations and health care groups already on the ground – making sure everything from simple antibiotic creams to critical medicines were made accessible to victims. And the more the need for medicinal aid is defined, the more our companies are providing it."

Some of the medical and disaster relief organizations that PhRMA companies are coordinating with in Haiti include the World Health Organization, UNICEF and the Red Cross (via various national associations), as well as Americares, Catholic Medical Mission Board, Direct Relief International, MAP International, Partners in Health, Project HOPE, Save the Children and World Vision.

PhRMA is also involved in the Haitian effort through the Rx Response program.  This program, which was developed following Hurricane Katrina, has shed light on the most effective methods to donate medical products and the most efficient ways medical professionals can volunteer for the Haiti response effort.

"The vital role of PhRMA companies and their employees in the global community is clearly defined by such catastrophic situations.  It's our civic responsibility to provide health care professionals the tools they need to help save lives, and we're proud to take part in this effort, which will lead to the eventual recovery of Haiti," Tauzin said.

The Pharmaceutical Research and Manufacturers of America   (PhRMA) represents the country's leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA companies are leading the way in the search for new cures. PhRMA members alone invested an estimated $50.3 billion in 2008 in discovering and developing new medicines. Industry-wide research and investment reached a record $65.2 billion in 2008.

PhRMA Internet Address: http://www.phrma.org

For information on stories of hope and survival, visit: http://sharingmiracles.com/

For information on how innovative medicines save lives, visit: http://www.innovation.org

For information on the Partnership for Prescription Assistance, visit: http://www.pparx.org

For more information on public health emergencies, visit http://www.rxresponse.org

For information on the danger of imported drugs, visit: http://www.buysafedrugs.info

SOURCE Pharmaceutical Research and Manufacturers of America

RELATED LINKS
http://www.phrma.org/

'/>"/>

SOURCE Pharmaceutical Research and Manufacturers of America
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Pres. Clinton Announces Commitment From Inter-American Development Bank, Global Network for Neglected Tropical Diseases, and Pan American Health Organization to Mobilize $30 Million to Fight NTDs in the Americas at CGI Conference
2. Accuray Announces Regionalized Management Strategy for Americas
3. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
7. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
8. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
9. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
10. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
11. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... FRANCISCO, Calif. , June 24, 2016 /PRNewswire/ ... ), a biopharmaceutical company developing novel therapeutics for ... unmet needs, today announced the closing of its ... of common stock, at the public offering price ... in the offering were offered by GBT. GBT ...
(Date:6/24/2016)... DUBLIN , June 24, 2016 ... and Markets has announced the addition of the ... their offering. ... products and provides an updated review, including its applications ... covering the total market, which includes three main industries: ...
(Date:6/24/2016)... The Academy of Managed Care Pharmacy (AMCP) ... would allow biopharmaceutical companies to more easily share health ... and coverage decisions, a move that addresses the growing ... The recommendations address restrictions in the sharing of ... label, a prohibition that hinders decision makers from accessing ...
Breaking Medicine Technology:
(Date:6/25/2016)... , ... June 25, 2016 , ... Austin residents seeking ... American College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical ... effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
(Date:6/24/2016)... , ... June 24, 2016 , ... June 19, 2016 ... dangers associated with chronic pain and the benefits of holistic treatments, Serenity Recovery ... are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder ...
(Date:6/24/2016)... ... , ... Comfort Keepers® of San Diego, CA is excited to announce they ... to drive cancer patients to and from their cancer treatments. Comfort Keepers provides ... life and ongoing independence. Getting to and from medical treatments is one of ...
(Date:6/24/2016)... ... 24, 2016 , ... Puradigm® & Innovative Solutions today announced ... and processing operations at its production facility, and opened its first two dispensaries ... manufacturer of a complete system of proactive air and surface purification solutions for ...
Breaking Medicine News(10 mins):